Pharsight

Drugs that contain Amlodipine Benzoate

1. Katerzia patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11364230 AZURITY Amlodipine formulations
Oct, 2037

(13 years from now)

US10959991 AZURITY Amlodipine formulations
Oct, 2037

(13 years from now)

US10894039 AZURITY Amlodipine formulations
Oct, 2037

(13 years from now)

US11471409 AZURITY Amlodipine formulations
Oct, 2037

(13 years from now)

US11918685 AZURITY Amlodipine formulations
Oct, 2037

(13 years from now)

US11701326 AZURITY Amlodipine formulations
Oct, 2037

(13 years from now)

US11484498 AZURITY Amlodipine formulations
Oct, 2037

(13 years from now)

US10952998 AZURITY Amlodipine formulations
Oct, 2037

(13 years from now)

US10695329 AZURITY Amlodipine formulations
Oct, 2037

(13 years from now)

US10799453 AZURITY Amlodipine formulations
Apr, 2039

(14 years from now)

Market Authorisation Date: 08 July, 2019

Treatment: Angina; Method of treating hypertension; A method of treating hypertension

Dosage: SUSPENSION;ORAL

How can I launch a generic of KATERZIA before it's drug patent expiration?
More Information on Dosage

KATERZIA family patents

Family Patents